SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Hypothermia Trial Yields Null Result in Brain Injuries, University of Texas Medical School Study
December 29, 2010
 · 
1 min read
Lone Star Bio
Poor Response to Anti-Anemia Drug Predicts Higher Risk of Heart Disease Or Death, UT Southwestern Medical Center Study
December 29, 2010
 · 
1 min read
Lone Star Bio
New Clues Uncover How “Starvation Hormone” Works, UT Southwestern Medical Center Study
December 27, 2010
 · 
1 min read
Lone Star Bio
Medical Robotics To Improve Heart Surgery, University of Houston and The Methodist Hospital Reveal
December 20, 2010
 · 
1 min read
Lone Star Bio
Keeping Holiday Drinking in Check May Counter Cancer, University of Texas MD Anderson Cancer Center Reveals
December 20, 2010
 · 
1 min read
Lone Star Bio
SABCS: Antibody Combo Promising in HER2 Breast Cancer
December 15, 2010
 · 
1 min read
Lone Star Bio
Nanowire Heart Pumps Next-Gen Battery, Rice University Study
December 13, 2010
 · 
1 min read
Lone Star Bio
Local Startups Like Texas Medical Center Bank on New Medical Technology
December 10, 2010
 · 
3 min read
Lone Star Bio
New Blood Test Could Detect Heart Disease in People With No Symptoms, UT Southwestern Medical Center Finds
December 8, 2010
 · 
1 min read
Lone Star Bio
Researchers Study New Test to Prevent Overuse of Antibiotics in Pregnant Women, University of Texas Health Science Center Study
November 29, 2010
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Load More